Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AARS | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
mRNA | AARS2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
mRNA | AATF | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
mRNA | ABCA7 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
mRNA | ABCA8 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
mRNA | ABCA9 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ABCB4 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
mRNA | ABCB5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ABCD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
mRNA | ABHD18 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |